메뉴 건너뛰기




Volumn 56, Issue 4, 2011, Pages 560-589

Uridine phosphorylase in biomedical, structural, and functional aspects: A review

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-CANCER AGENTS; CHEMOTHERAPEUTIC TREATMENTS; FUNCTIONAL ASPECTS; KEY ENZYMES; MALIGNANT TUMORS; MEDICINAL PREPARATION; REVERSIBLE PHOSPHORYLATION;

EID: 80052674090     PISSN: 10637745     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1063774511040122     Document Type: Review
Times cited : (12)

References (87)
  • 7
    • 0019826126 scopus 로고
    • 10.1016/S0190-9622(81)80196-X
    • D. K. Goette 1981 J. Am. Acad. Dermatol. 4 6 633 10.1016/S0190-9622(81) 80196-X
    • (1981) J. Am. Acad. Dermatol. , vol.4 , Issue.6 , pp. 633
    • Goette, D.K.1
  • 8
    • 0023265890 scopus 로고
    • 10.1002/ssu.2980030312
    • N. Kemeny 1987 Semin. Surg. Oncol. 3 3 190 10.1002/ssu.2980030312
    • (1987) Semin. Surg. Oncol. , vol.3 , Issue.3 , pp. 190
    • Kemeny, N.1
  • 11
    • 0020655660 scopus 로고
    • Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases
    • DOI 10.1016/0006-2952(83)90517-8
    • J. G. Niedzwicki M. H. El Kouni S. H. Chu, et al. 1983 Biochem. Pharmacol. 32 3 399 10.1016/0006-2952(83)90517-8 (Pubitemid 13184543)
    • (1983) Biochemical Pharmacology , vol.32 , Issue.3 , pp. 399-415
    • Niedzwicki, J.G.1    El Kouni, M.H.2    Chu, S.H.3    Cha, S.4
  • 20
    • 0020037313 scopus 로고
    • 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase
    • DOI 10.1016/0006-2952(82)90488-9
    • J. G. Niedzwicki S. H. Chu M. H. El Kouni, et al. 1982 Biochem. Pharmacol. 31 10 1857 10.1016/0006-2952(82)90488-9 (Pubitemid 12123092)
    • (1982) Biochemical Pharmacology , vol.31 , Issue.10 , pp. 1857-1861
    • Niedzwicki, J.G.1    Chu, S.H.2    El Kouni, M.H.3
  • 21
    • 0023023142 scopus 로고
    • Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines
    • DOI 10.1016/0006-2952(86)90675-1
    • K. S. Park M. H. El Kouni T. A. Krenitsky, et al. 1986 Biochem. Pharmacol. 35 21 3853 10.1016/0006-2952(86)90675-1 (Pubitemid 17180438)
    • (1986) Biochemical Pharmacology , vol.35 , Issue.21 , pp. 3853-3855
    • Kyung Sun Park1    El Kouni, M.H.2    Krenitsky, T.A.3
  • 30
    • 0032992733 scopus 로고    scopus 로고
    • Uridine and its nucleotides: Biological actions, therapeutic potentials
    • DOI 10.1016/S0165-6147(99)01298-5, PII S0165614799012985
    • G. P. Connolly J. A. Duley 1999 Trends Pharmacol Sci. 20 5 218 10.1016/S0165-6147(99)01298-5 (Pubitemid 29249057)
    • (1999) Trends in Pharmacological Sciences , vol.20 , Issue.5 , pp. 218-225
    • Connolly, G.P.1    Duley, J.A.2
  • 31
    • 0014190663 scopus 로고
    • 1967Sci.156.1237L 10.1126/science.156.3779.1237
    • Z. J. Lucas 1967 Science 156 779 1237 1967Sci...156.1237L 10.1126/science.156.3779.1237
    • (1967) Science , vol.156 , Issue.779 , pp. 1237
    • Lucas, Z.J.1
  • 32
    • 0020604076 scopus 로고
    • Purine and pyrimidine metabolism in peripheral blood lymphocytes
    • DOI 10.1016/0020-711X(83)90051-4
    • G. J. Peters J. H. Veerkamp 1983 Int. J. Biochem. 15 2 115 10.1016/0020-711X(83)90051-4 (Pubitemid 13115657)
    • (1983) International Journal of Biochemistry , vol.15 , Issue.2 , pp. 115-123
    • Peters, G.J.1    Veerkamp, J.H.2
  • 33
    • 0019519002 scopus 로고
    • 1981Sci.213.777G 10.1126/science.7256279
    • T. Gasser J. D. Moyer R. E. Handschumacher 1981 Science 213 4509 777 1981Sci...213..777G 10.1126/science.7256279
    • (1981) Science , vol.213 , Issue.4509 , pp. 777
    • Gasser, T.1    Moyer, J.D.2    Handschumacher, R.E.3
  • 36
    • 0022004718 scopus 로고
    • Salvage of uridine in the mouse. Effect of uridine phosphorylase pretreatment
    • DOI 10.1016/0006-2952(85)90107-8
    • J. D. Moyer J. F. Henderson 1985 Biochem. Pharmacol. 34 1 101 10.1016/0006-2952(85)90107-8 (Pubitemid 15196381)
    • (1985) Biochemical Pharmacology , vol.34 , Issue.1 , pp. 101-105
    • Moyer, J.D.1    Henderson, J.F.2
  • 41
    • 0031013944 scopus 로고    scopus 로고
    • Seeking the nucleoside transporter
    • DOI 10.1038/nm0197-25
    • J. S. Wiley 1997 Nat. Med. 3 1 25 10.1038/nm0197-25 (Pubitemid 27019133)
    • (1997) Nature Medicine , vol.3 , Issue.1 , pp. 25-26
    • Wiley, J.S.1
  • 44
    • 0036179144 scopus 로고    scopus 로고
    • 10.1016/S0959-8049(01)00414-2
    • M. Venturini 2002 Eur. J. Cancer 38 Suppl.2 3 10.1016/S0959-8049(01) 00414-2
    • (2002) Eur. J. Cancer , vol.38 , Issue.SUPPL.2 , pp. 3
    • Venturini, M.1
  • 45
    • 0037252519 scopus 로고    scopus 로고
    • Capecitabine: A review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer
    • DOI 10.2165/00003495-200363020-00009
    • A. J. Wagstaff T. Ibbotson K. L. Goa 2003 Drugs 63 2 217 10.2165/00003495-200363020-00009 (Pubitemid 36143347)
    • (2003) Drugs , vol.63 , Issue.2 , pp. 217-236
    • Wagstaff, A.J.1    Ibbotson, T.2    Goa, K.L.3
  • 49
    • 0032856558 scopus 로고    scopus 로고
    • Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models
    • DOI 10.1002/(SICI)1097-0215(19990924)83:1<127::AID-IJC22>3.0.CO;2-6
    • M. Endo N. Shinbori Y. Fukase, et al. 1999 Int. J. Cancer 83 1 127 10.1002/(SICI)1097-0215(19990924)83:1<127::AID-IJC22>3.0.CO;2-6 (Pubitemid 29409488)
    • (1999) International Journal of Cancer , vol.83 , Issue.1 , pp. 127-134
    • Endo, M.1    Shinbori, N.2    Fukase, Y.3    Sawada, N.4    Ishikawa, T.5    Ishitsuka, H.6    Tanaka, Y.7
  • 52
    • 0035342546 scopus 로고    scopus 로고
    • Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA
    • DOI 10.1002/ijc.1212
    • T. Morita A. Matsuzaki A. Tokue 2001 Int. J. Cancer 92 3 451 10.1002/ijc.1212 (Pubitemid 32249725)
    • (2001) International Journal of Cancer , vol.92 , Issue.3 , pp. 451-456
    • Morita, T.1    Matsuzaki, A.2    Tokue, A.3
  • 59
    • 0024246767 scopus 로고
    • Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy
    • DOI 10.1111/j.1432-1033.1988.tb14441.x
    • Z. Veres A. Neszmelyi A. Szabolcs, et al. 1988 Eur. J. Biochem. 178 1 173 10.1111/j.1432-1033.1988.tb14441.x (Pubitemid 19010196)
    • (1988) European Journal of Biochemistry , vol.178 , Issue.1 , pp. 173-181
    • Veres, Z.1    Neszmelyi, A.2    Szabolcs, A.3    Denes, G.4
  • 62
    • 0023277204 scopus 로고
    • New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers
    • DOI 10.1016/0006-2952(87)90150-X
    • F. N. Naguib M. H. E. Kouni S. H. Chu, et al. 1987 Biochem. Pharmacol. 36 13 2195 10.1016/0006-2952(87)90150-X (Pubitemid 17101734)
    • (1987) Biochemical Pharmacology , vol.36 , Issue.13 , pp. 2195-2201
    • Naguib, F.N.M.1    El Kouni, M.H.2    Chu, S.3    Cha, S.4
  • 71
    • 1442348235 scopus 로고    scopus 로고
    • Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium
    • DOI 10.1016/j.jmb.2004.01.039, PII S0022283604001093
    • T. T. Caradoc-Davies S. M. Cutfield I. L. Lamont, et al. 2004 J. Mol. Biol. 337 2 337 10.1016/j.jmb.2004.01.039 (Pubitemid 38293403)
    • (2004) Journal of Molecular Biology , vol.337 , Issue.2 , pp. 337-354
    • Caradoc-Davies, T.T.1    Cutfield, S.M.2    Lamont, I.L.3    Cutfield, J.F.4
  • 78
    • 77958616332 scopus 로고    scopus 로고
    • 10.1371/journal.pone.0012741 741
    • T. P. Roosild S. Castronovo 2010 PLoS One 5 9 e12 741 10.1371/journal.pone.0012741
    • (2010) PLoS One , vol.5 , Issue.9 , pp. 12
    • Roosild, T.P.1    Castronovo, S.2
  • 82
    • 80052653975 scopus 로고    scopus 로고
    • LLC, New York (New York)
    • Maestro, Schrödinger, LLC, New York (New York, 2009).
    • (2009) Maestro, Schrödinger
  • 85
    • 0022214278 scopus 로고
    • Role of uridine phosphorylase in the anabolism of 5-fluorouracil
    • DOI 10.1016/0006-2952(85)90737-3
    • P. M. Schwartz R. D. Moir C. M. Hyde, et al. 1985 Biochem. Pharmacol. 34 19 3585 10.1016/0006-2952(85)90737-3 (Pubitemid 16252540)
    • (1985) Biochemical Pharmacology , vol.34 , Issue.19 , pp. 3585-3589
    • Schwartz, P.M.1    Moir, R.D.2    Hyde, C.M.3
  • 86
    • 0025351196 scopus 로고
    • Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas
    • DOI 10.1002/1097-0142(19900701)66:1<156::AID-CNCR2820660128>3.0. CO;2-R
    • Y. Maehara S. Moriguchi Y. Emi, et al. 1990 Cancer 66 1 156 10.1002/1097-0142(19900701)66:1<156::AID-CNCR2820660128>3.0.CO;2-R (Pubitemid 20197101)
    • (1990) Cancer , vol.66 , Issue.1 , pp. 156-161
    • Maehara, Y.1    Moriguchi, S.2    Emi, Y.3    Watanabe, A.4    Kohnoe, S.5    Tsujitani, S.6    Sugimachi, K.7
  • 87
    • 80052650057 scopus 로고    scopus 로고
    • LLC, New York (New York)
    • CombiGlide, Schrödinger, LLC, New York (New York, 2007).
    • (2007) CombiGlide, Schrödinger


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.